General Information of the Compound
| Compound ID |
CP0389768
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
N,N'-bis[3-chloro-6-(4-methylpiperazin-1-yl)benzo[b][1,4]benzodiazepin-11-yl]tetradecanediamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C50H62Cl2N10O2
|
||||||||||||||||||
| Molecular Weight |
906.02
|
||||||||||||||||||
| Canonical SMILES |
CN1CCN(CC1)C1=Nc2cc(Cl)ccc2N(NC(=O)CCCCCCCCCCCCC(=O)NN2c3ccc(Cl)cc3N=C(N3CCN(C)CC3)c3ccccc23)c2ccccc12
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C50H62Cl2N10O2/c1-57-27-31-59(32-28-57)49-39-17-13-15-19-43(39)61(45-25-23-37(51)35-41(45)53-49)55-47(63)21-11-9-7-5-3-4-6-8-10-12-22-48(64)56-62-44-20-16-14-18-40(44)50(60-33-29-58(2)30-34-60)54-42-36-38(52)24-26-46(42)62/h13-20,23-26,35-36H,3-12,21-22,27-34H2,1-2H3,(H,55,63)(H,56,64)
Show/Hide
|
||||||||||||||||||
| InChIKey |
ACYRRFBCTGQMNI-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound